Sign in

CIK 0000771856 · Non-accelerated filer<br>Smaller reporting company

CHAMPIONS ONCOLOGY, INC.

Sign in to watch
Ticker
CSBR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Apr 30
Incorporated
DE
Entity type
operating
EIN
521401755
Phone
410-369-0365
Business address
855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
Former names
CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 8-K Event Shareholder vote results
  5. 8-K Event Executive or director change
  6. 4 Open-market buy Director bought 4,000 shares at $6.16 ($24,640)
  7. 4 Open-market buy Director bought 5,000 shares at $6.22 ($31,100)
  8. 4 Open-market buy Director bought 1,500 shares at $5.95 ($8,925)
  9. 4 Open-market buy Director bought 5,000 shares at $6.40 ($32,000)
  10. 4 Open-market buy Director bought 1,100 shares at $6.41 ($7,051)
  11. 4 Open-market buy Director bought 1,530 shares at $6.48 ($9,914)
  12. 4 Open-market buy Director bought 2,000 shares at $6.47 ($12,940)
  13. 4 Open-market buy Director bought 2,500 shares at $6.30 ($15,750)
  14. 4 Open-market buy Director bought 5,000 shares at $6.40 ($32,000)
  15. 4 Open-market buy Director bought 5,000 shares at $5.65 ($28,250)
  16. 4 Open-market buy Director bought 5,000 shares at $5.28 ($26,400)
  17. 4 Open-market buy Director bought 4,018 shares at $5.51 ($22,139)
  18. 4 Open-market buy Director bought 5,000 shares at $5.51 ($27,550)
  19. 4 Open-market buy Director bought 3,812 shares at $5.50 ($20,966)
  20. 10-Q Report Quarterly Report

Page 5 of 33 · 659 filings